This guidance evaluates new, innovative medical devices and diagnostics.
It looks at medical technologies that:
- deliver treatment - like those implanted during surgical procedures
- give greater independence to patients
- detect or monitor medical conditions.
Our aim is to boost the uptake of devices and technologies in the NHS.
Get a technology evaluated
Tell us about a medical technology and we will consider it for guidance.
Anyone can notify us of a technology for consideration.
Medical technologies guidance
Our guidance helps people in the NHS make efficient, cost-effective and consistent decisions about adopting new medical technologies.
It supports innovation and transformation and improves healthcare delivery.
Find out more about:
- the process timeline
- how we select technologies
- who makes decisions
- our process and methods guides.
To get involved, you can:
- comment on draft recommendations
- take part in guidance development as a stakeholder
- attend a committee meeting.
These short briefings examine new, innovative technologies. Each one provides:
- a description of the new technology
- examples of use
- its role in the treatment pathway
- reviews of published evidence
- likely costs.
Digital health technologies pilot
We are piloting a process for developing guidance on 4 digital health technologies.
After the pilot has finished, we will review the process to determine how best to develop guidance on the technologies in the future.
We regularly review our medical technologies guidance. If there is no new research or evidence available that would have a material effect on the guidance, it gets moved to the static list. If new evidence becomes available, the guidance can be transferred back to the active list for further appraisal.
The following guidance has been transferred to the static list.
|Ref||Title||Date issued||Review decision|
|MTG1||SeQuent Please balloon catheter for in-stent coronary restenosis||December 2010||MTG1 Review decision|
|MTG3||CardioQ-ODM oesophageal doppler monitor||March 2011||MTG3 Review decision|
|MTG5||The MIST Therapy system for the promotion of wound healing||July 2010||MTG5 Review decision|
|MTG6||Ambulight PDT for the treatment of non-melanoma skin cancer||March 2019||MTG6 Review decision|
|MTG11||Mega Soft Patient Return Electrode for use during monopolar electrosurgery||August 2012||MTG11 Review decision|
|MTG19||The geko device for reducing the risk of venous thromboembolism||June 2014||MTG19 Review decision|
|MTG21||The ReCell Spray On Skin system for treating skin loss, scarring and depigmentation after burn injury||August 2020||MTG21 Review decision|
|MTG22||VibraTip for testing vibration perception to detect diabetic peripheral neuropathy||December 2014||MTG22 Review decision|
|MTG30||XprESS multi sinus dilation system for treating chronic sinusitis||July 2020||MTG30 Review decision|